Gene therapy of human melanoma. Immunization of patients with autologous tumor cells admixed with allogeneic melanoma cells secreting interleukin 6 and soluble interleukin 6 receptor

Hum Gene Ther. 1995 Jun;6(6):805-11. doi: 10.1089/hum.1995.6.6-805.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, CD / genetics*
  • Antigens, CD / metabolism
  • Clinical Protocols
  • Genetic Therapy*
  • Humans
  • Immunotherapy
  • Informed Consent
  • Interleukin-6 / genetics*
  • Interleukin-6 / metabolism
  • Interleukin-6 / therapeutic use
  • Melanoma / genetics*
  • Melanoma / immunology
  • Melanoma / metabolism
  • Melanoma / therapy
  • Mice
  • Patient Selection
  • Receptors, Interleukin / genetics*
  • Receptors, Interleukin / metabolism
  • Receptors, Interleukin-6

Substances

  • Antigens, CD
  • Interleukin-6
  • Receptors, Interleukin
  • Receptors, Interleukin-6